2023³â ´ëÇÑ°©»ó¼±ÇÐȸ Ãß°èÇмú´ëȸ (1ÀÏÂ÷) : 2023-08-25
±³À°ÀÏÀÚ : 2023-08-25
±³À°Àå¼Ò : ¼¼Á¾´ëÇб³ ±¤°³Åä°ü ÄÁº¥¼Ç¼¾ÅÍ
±³À°ÁÖÁ¦ : 2023³â ´ëÇÑ°©»ó¼±ÇÐȸ Ãß°èÇмú´ëȸ (1ÀÏÂ÷)
ÁÖÃÖ±â°ü : ´ëÇÑ°©»ó¼±ÇÐȸ
´ã´çÀÚ : ÀÌÀçÀº
¿¬¶ôó : 02-743-0320
À̸ÞÀÏ : office@thyroid.kr
±³À°Á¾·ù : ³»°ú, ¿Ü°ú, À̺ñÀÎÈÄ°ú, ¿µ»óÀÇÇаú, º´¸®°ú, ÇÙÀÇÇаú
Âü¼®¿¹»óÀÎ : 350¸í
Èñ¸ÁÆòÁ¡ : 4Á¡
Áö¿ª : ¼¿ïƯº°½Ã
±³À°½Ã°£ : 8 ½Ã°£ 20ºÐ
¼¼ºÎ¼ö°·á : 120,000¿ø
ºñ°í 1. Àü¹®ÀÇ/ÀϹÝÀÇ 1) Æò»ýȸ¿ø ¹× Á¤È¸¿ø(¿¬È¸ºñ ³³ºÎÀÚ) »çÀüµî·Ï 90,000¿ø, ÇöÀåµî·Ï 110,000¿ø, 2) ºñȸ¿ø »çÀüµî·Ï 100,000¿ø, ÇöÀåµî·Ï 120,000¿ø 2. Àü°øÀÇ/±ºÀÇ°ü/°øÁߺ¸°ÇÀÇ/°£È£»ç/±âÃÊÀÇÇÐÀÚ 1) Æò»ýȸ¿ø ¹× Á¤È¸¿ø(¿¬È¸ºñ ³³ºÎÀÚ) »çÀüµî·Ï 50,000¿ø, ÇöÀåµî·Ï 70,000¿ø, 2) ºñȸ¿ø »çÀüµî·Ï 70,000¿ø, ÇöÀåµî·Ï 90,000¿ø 3. ¸¸65¼¼ ÀÌ»óÀÎ Æò»ýȸ¿ø, Çкλý ¹× ÀÇÀü¿ø Çлý : ¹«·á
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 08¿ù 25ÀÏ ÄÁº¥¼ÇȦ C 13:05~13:25 Recurred Tumor: Imaging Feature and Biopsy Strategy À̹ΰæ(°¡Å縯ÀÇ´ë ¿µ»óÀÇÇаú)
±³À°½Ã°£ 08¿ù 25ÀÏ ÄÁº¥¼ÇȦ C 13:25~13:45 Post-Op. Imaging of Thyroid Cancer: Various Pathology Á¤¼Ò¿µ(¼¿ïÀÇ´ë ¿µ»óÀÇÇаú)
±³À°½Ã°£ 08¿ù 25ÀÏ ÄÁº¥¼ÇȦ C 13:45~14:05 Post-Op Nuclear Imaging of Thyroid Cancer ȫä¹®(°æºÏÀÇ´ë ÇÙÀÇÇаú)
Åä·Ð 08¿ù 25ÀÏ ÄÁº¥¼ÇȦ C 14:05~14:15 ÅäÀÇ ()
±³À°½Ã°£ 08¿ù 25ÀÏ ÄÁº¥¼ÇȦ C 14:15~14:35 ºÎ°©»ó¼± ÁúȯÀÇ Æ®·»µå ¹× ¼ö¼úÀûÀÀÁõ Á¤Á¾ÁÖ(¿¬¼¼ÀÇ´ë ¿Ü°ú)
±³À°½Ã°£ 08¿ù 25ÀÏ ÄÁº¥¼ÇȦ C 14:35~14:55 ºÎ°©»ó¼± ÁúȯÀÇ ¼ö¼ú À̺´ÁÖ(ºÎ»êÀÇ´ë À̺ñÀÎÈÄ°ú)
±³À°½Ã°£ 08¿ù 25ÀÏ ÄÁº¥¼ÇȦ C 14:55~15:15 ºÎ°©»ó¼± ÁúȯÀÇ º´¸® ±ÇÇüÁÖ(¿¬¼¼ÀÇ´ë º´¸®°ú)
Åä·Ð 08¿ù 25ÀÏ ÄÁº¥¼ÇȦ C 15:15~15:25 ÅäÀÇ ()
ÈÞ½Ä 08¿ù 25ÀÏ ÄÁº¥¼ÇȦ C 15:25~15:45 Coffee Break ()
±³À°½Ã°£ 08¿ù 25ÀÏ ÄÁº¥¼ÇȦ C 15:45~16:35 Management of Locally Advanced or Unresectable Thyroid Cancer Shigeru Hirano(Kyoto Prefectural University, Japan)
±³À°½Ã°£ 08¿ù 25ÀÏ ÄÁº¥¼ÇȦ C 16:35~16:55 ¼ö¼ú ÈÄ ÈäÅÍ°ü¸® ¹Ú±Í¿µ(Áß¾ÓÀÇ´ë ÇǺΰú)
±³À°½Ã°£ 08¿ù 25ÀÏ ÄÁº¥¼ÇȦ C 16:55~17:15 ¼ö¼ú ÈÄ À¯Âø, ÀçÈ° ¿ì½ÂÈÆ(´Ü±¹ÀÇ´ë À̺ñÀÎÈÄ°ú)
±³À°½Ã°£ 08¿ù 25ÀÏ ÄÁº¥¼ÇȦ C 17:15~17:35 ¼ö¼ú ÈÄ Á¤½Å°Ç° °ü¸® Á¤¼®ÈÆ(¿ï»êÀÇ´ë Á¤½Å°ú)
Åä·Ð 08¿ù 25ÀÏ ÄÁº¥¼ÇȦ C 17:35~17:45 ÅäÀÇ ()
±³À°½Ã°£ 08¿ù 25ÀÏ ÄÁº¥¼ÇȦ B 13:05~13:15 [±¸¿¬¹ßÇ¥] Extent of thyroidectomy for solitary papillary thyroid carcinoma confined in the isthmus À̽ÂÈ£(¼¿ï´ëÇб³º´¿ø ¿Ü°ú)
±³À°½Ã°£ 08¿ù 25ÀÏ ÄÁº¥¼ÇȦ B 13:15~13:25 [±¸¿¬¹ßÇ¥] Comparison of Delayed Bleeding to Immediate Bleeding Following Thyroidectomy ÀÌÁؼº(°³²¼¼ºê¶õ½ºº´¿ø ¿Ü°ú)
±³À°½Ã°£ 08¿ù 25ÀÏ ÄÁº¥¼ÇȦ B 13:25~13:35 [±¸¿¬¹ßÇ¥] TSH Receptor Antibody as a Predictive Factor for Difficult Robotic Thyroidectomy in Graves' Disease Patients ÀÌÀÚ°æ(ºÐ´ç¼¿ï´ëÇб³º´¿ø ¿Ü°ú)
±³À°½Ã°£ 08¿ù 25ÀÏ ÄÁº¥¼ÇȦ B 13:35~13:45 [±¸¿¬¹ßÇ¥] Longitudinal changes of quality of life before and after thyroidectomy in patients with differentiated thyroid cancer ±èº´ÈÆ(ÇѾç´ëÇб³º´¿ø À̺ñÀÎÈÄ°ú)
±³À°½Ã°£ 08¿ù 25ÀÏ ÄÁº¥¼ÇȦ B 13:45~13:55 [±¸¿¬¹ßÇ¥] Swallowing outcomes measured by a self-reported questionnaire after transoral robotic thyroidectomy: comparison with conventional trans-cervical thyroidectomy À̽¿(ÇѾç´ëÇб³º´¿ø À̺ñÀÎÈÄ°ú)
±³À°½Ã°£ 08¿ù 25ÀÏ ÄÁº¥¼ÇȦ B 13:55~14:05 [±¸¿¬¹ßÇ¥] Long-Term Outcomes of Prophylactic Bilateral Lateral Neck Dissection in Medullary Thyroid Carcinoma ¹Ú½ÅÁ¤(¼¿ï¾Æ»êº´¿ø ¿Ü°ú)
±³À°½Ã°£ 08¿ù 25ÀÏ ÄÁº¥¼ÇȦ B 14:15~14:25 [±¸¿¬¹ßÇ¥] Feasibility of Active Surveillance in Patients with Clinically T1b Papillary Thyroid Carcinoma ¡Â1.5cm in Preoperative Ultrasonography: MASTER Study ÁÖ»óÇö(Ãæ³²´ëÇб³º´¿ø ³»°ú)
±³À°½Ã°£ 08¿ù 25ÀÏ ÄÁº¥¼ÇȦ B 14:25~14:35 [±¸¿¬¹ßÇ¥] Risk factors associated with high-risk nodal disease in patients considered for active surveillance of papillary thyroid microcarcinoma without extrathyroidal extension ¿©ÅÂÈÆ(¿©Àǵµ¼º¸ðº´¿ø ¿Ü°ú)
±³À°½Ã°£ 08¿ù 25ÀÏ ÄÁº¥¼ÇȦ B 14:35~14:45 [±¸¿¬¹ßÇ¥] Initial Clinical Outcomes of Papillary Thyroid Cancer with TERT Promoter Mutation from Real World Data À¯ÁöÇö(»ï¼º¼¿ïº´¿ø ³»°ú)
±³À°½Ã°£ 08¿ù 25ÀÏ ÄÁº¥¼ÇȦ B 14:45~14:55 [±¸¿¬¹ßÇ¥] Tranoral robotic thyroidectomy vs transoral endoscopic thyroidectomy vestibular approach ÀÌÁؼº(°³²¼¼ºê¶õ½ºº´¿ø ¿Ü°ú)
±³À°½Ã°£ 08¿ù 25ÀÏ ÄÁº¥¼ÇȦ B 14:55~15:05 [±¸¿¬¹ßÇ¥] Transaxillary robotic parathyroidectomy : preliminary experience in patients with primary hyperparathyroidism À̼±¹Î(¼¼ºê¶õ½ºº´¿ø ¿Ü°ú)
±³À°½Ã°£ 08¿ù 25ÀÏ ÄÁº¥¼ÇȦ B 15:05~15:15 [±¸¿¬¹ßÇ¥] Survey results comparing patient satisfaction with transoral thyroidectomy versus open thyroidectomy ÀÌÁؼº(°³²¼¼ºê¶õ½ºº´¿ø ¿Ü°ú)
±³À°½Ã°£ 08¿ù 25ÀÏ ÄÁº¥¼ÇȦ B 15:45~16:35 °©»ó¼±¾Ï ¿¬±¸¿¡ ÀÖ¾î¼ ¿¹¹æÀÇÇÐÀû ¹æ¹ýÀÇ È°¿ë ¹Ú¼ö°æ(¼¿ïÀÇ´ë ¿¹¹æÀÇÇаú)
±³À°½Ã°£ 08¿ù 25ÀÏ ÄÁº¥¼ÇȦ B 16:35~16:55 Diagnostic Cell-Free Circulating MicroRNA for Papillary Thyroid Cancer: Preliminary Results ¿øÈ£·û(Ãæ³²ÀÇ´ë À̺ñÀÎÈÄ°ú)
±³À°½Ã°£ 08¿ù 25ÀÏ ÄÁº¥¼ÇȦ B 16:55~17:15 Long-Term Managements of Thyroid Cancer in Korea: A Nationwide Cohort Study ±è°æÁø(°í·ÁÀÇ´ë ³»°ú)
±³À°½Ã°£ 08¿ù 25ÀÏ ÄÁº¥¼ÇȦ B 17:15~17:35 Analysis of Factors Affecting the Quality of Life by Age Group in Patients Undergoing Thyroidectomy for Thyroid Cancer ±è¼ö¿µ(¾ÆÁÖÀÇ´ë ¿Ü°ú)
Åä·Ð 08¿ù 25ÀÏ ÄÁº¥¼ÇȦ B 17:35~17:45 ÅäÀÇ ()